159 related articles for article (PubMed ID: 21824269)
1. Metabolic impact of glucagon deficiency.
Hayashi Y
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():151-7. PubMed ID: 21824269
[TBL] [Abstract][Full Text] [Related]
2. A switch from prohormone convertase (PC)-2 to PC1/3 expression in transplanted alpha-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice.
Wideman RD; Covey SD; Webb GC; Drucker DJ; Kieffer TJ
Diabetes; 2007 Nov; 56(11):2744-52. PubMed ID: 17698597
[TBL] [Abstract][Full Text] [Related]
3. Aristaless-related homeobox plays a key role in hyperplasia of the pancreas islet α-like cells in mice deficient in proglucagon-derived peptides.
Xu S; Hayashi Y; Takagishi Y; Itoh M; Murata Y
PLoS One; 2013; 8(5):e64415. PubMed ID: 23671715
[TBL] [Abstract][Full Text] [Related]
4. Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells.
Hayashi Y; Yamamoto M; Mizoguchi H; Watanabe C; Ito R; Yamamoto S; Sun XY; Murata Y
Mol Endocrinol; 2009 Dec; 23(12):1990-9. PubMed ID: 19819987
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
Kedees MH; Grigoryan M; Guz Y; Teitelman G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
[TBL] [Abstract][Full Text] [Related]
8. Growth factor signalling in the regulation of α-cell fate.
Kawamori D; Akiyama M; Hu J; Hambro B; Kulkarni RN
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():21-30. PubMed ID: 21824253
[TBL] [Abstract][Full Text] [Related]
9. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
Jun LS; Millican RL; Hawkins ED; Konkol DL; Showalter AD; Christe ME; Michael MD; Sloop KW
Diabetes; 2015 Mar; 64(3):819-27. PubMed ID: 25288673
[TBL] [Abstract][Full Text] [Related]
10. Fertility and pregnancy-associated ß-cell proliferation in mice deficient in proglucagon-derived peptides.
Sugiyama C; Yamamoto M; Kotani T; Kikkawa F; Murata Y; Hayashi Y
PLoS One; 2012; 7(8):e43745. PubMed ID: 22928026
[TBL] [Abstract][Full Text] [Related]
11. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
[TBL] [Abstract][Full Text] [Related]
12. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.
Sandoval DA; D'Alessio DA
Physiol Rev; 2015 Apr; 95(2):513-48. PubMed ID: 25834231
[TBL] [Abstract][Full Text] [Related]
13. Islets of Langerhans from prohormone convertase-2 knockout mice show α-cell hyperplasia and tumorigenesis with elevated α-cell neogenesis.
Jones HB; Reens J; Brocklehurst SR; Betts CJ; Bickerton S; Bigley AL; Jenkins RP; Whalley NM; Morgan D; Smith DM
Int J Exp Pathol; 2014 Feb; 95(1):29-48. PubMed ID: 24456331
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of PC1/3-Expressing alpha-cells improves glucose handling and cold tolerance in leptin-resistant mice.
Wideman RD; Gray SL; Covey SD; Webb GC; Kieffer TJ
Mol Ther; 2009 Jan; 17(1):191-8. PubMed ID: 18941442
[TBL] [Abstract][Full Text] [Related]
15. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
Sloop KW; Cao JX; Siesky AM; Zhang HY; Bodenmiller DM; Cox AL; Jacobs SJ; Moyers JS; Owens RA; Showalter AD; Brenner MB; Raap A; Gromada J; Berridge BR; Monteith DK; Porksen N; McKay RA; Monia BP; Bhanot S; Watts LM; Michael MD
J Clin Invest; 2004 Jun; 113(11):1571-81. PubMed ID: 15173883
[TBL] [Abstract][Full Text] [Related]
16. Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice.
Lang S; Wei R; Wei T; Gu L; Feng J; Yan H; Yang J; Hong T
Peptides; 2020 Sep; 131():170349. PubMed ID: 32561493
[TBL] [Abstract][Full Text] [Related]
17. Gcg
Shiota C; Prasadan K; Guo P; Fusco J; Xiao X; Gittes GK
Diabetologia; 2017 Dec; 60(12):2399-2408. PubMed ID: 28884202
[TBL] [Abstract][Full Text] [Related]
18. The role of dysregulated glucagon secretion in type 2 diabetes.
D'Alessio D
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
20. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
Gelling RW; Du XQ; Dichmann DS; Romer J; Huang H; Cui L; Obici S; Tang B; Holst JJ; Fledelius C; Johansen PB; Rossetti L; Jelicks LA; Serup P; Nishimura E; Charron MJ
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1438-43. PubMed ID: 12552113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
